Novo Nordisk is confident its bid for U.S. drugmaker Metsera doesn't raise antitrust issues. The $8.5 billion offer tops Pfizer's $7.3 billion bid, sparking a legal dispute amid fierce competition in ...

Dow Jones Top Company Headlines at 7 PM ET: Palantir Revenue Climbs to Another Record as Defense Work Booms | Denny's ... The company said its sales were $1.18 billion in the third quarter for a ...

Pfizer has launched a second lawsuit against Novo Nordisk over its $9 billion bid for biotech company Metsera. Pfizer accuses ...

Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for biotech ...

Prosecutors said three American cybersecurity professionals secretly ran a ransomware operation aimed at shaking down ...